Clinical Trial Update: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating donor natural killer cells with cyclophosphamide and etoposide in children and young adults with relapsed or refractory solid tumors …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Cutaneous Melanoma
• Lip and Oral Cavity Cancer
• Malignant Mesothelioma
• Neuroendocrine Tumor
• Pharyngeal Cancer
• Soft Tissue Sarcoma
• Thyroid Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Donor natural killer cells
• Etoposide (Etoposide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma | Phase 1 | Status: TERMINATED